Chronic pancreatitis and underlying causes


Cite item

Full Text

References

  1. Steer M. L., Waxman I., Freedman S. Chronic pancreatitis. N. Engl. J. Med. 1995; 332: 1482-1490.
  2. Riela A., Zinsmeister A. R., Melton L. J. et al. Increasing incidence of pancreatic cancer among women in Olmsted Country, Minnesota, 1940 throught 1988. Mayo Clin. Proc. 1992; 67: 839-845.
  3. Robles-Diaz C., Vargas F., Uscanga L. et al. Chronic pancreatitis in Mexico City. Pancreas 1990; 5: 479-483.
  4. Lin Y., Tamakoshi A., Mutsuno S. et al. Nationwide epidemiological survey of chronic pancreatitis in Japan. J. Gastroenterol. 2000; 35: 136-141.
  5. Chart S. Т., Singer M. V. The problem of classification and staging of chronic pancreatitis: proposal based on current knowledge and its natural history. Scand. J. Gastroenterol. 1994; 29: 949-960.
  6. he Moine O., Devaster J. M., Deviere J. et al. Trypsin activity: A new marker of acute alcoholic pancreatitis. Dig. Dis. Sci. 1994; 39: 2634-2638.
  7. Lieber С. S. Metabolism of ethanol and associated hepatotoxicity. Drug Alcohol Rev. 1991; 10: 175-202.
  8. Лттапп R. W., Muellhaupt В., Croup Z. P. The natural history of pain in alcoholic chronic pancreatits. Gactroenterology 1999; 115: 1132-1140.
  9. Carey M. C., Fitzgerald O. Hyperparathyroidism associated with chronic pancreatitis in a family. Ibid. 1968; 9: 700-703.
  10. Freedman S. D., Sakamoto K., Venu R. P. GP2, the homologue to the renal cast protein uromodtiline is a major component of intraductal plugs in chronic pancreatitis. J. Clin. Invest. 1993; 92(1): 83-90.
  11. Bernard J. P., Aurich Z., Montana G. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine. Gastroenterology 1992; 103: 1277-1284.
  12. Apte M. V., Wilson J. S., McCaughan G. W. et al. Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J. Lab. Clin. Med. 1995; 125: 634-640.
  13. Wilson J. S., Apte M. V., Thomas M. С. et al. Effects of ethanol, acetaldehyde and cholesteryl esters on pancreatic lysosomes. Gut 1992; 33: 1099-1104.
  14. Haber P. S., Wilson J. S., Apte M. V. et al. Chronic ethanol consumption increases the fragility of rat pancreatic zymogen granules. Ibid. 1994; 35: 1474-1478.
  15. Haber P. S., Wilson J. S., Apte M. V. et al. Ethanol oxidation by pancreatic acinar cells is comparable to that of hepatocytes. Gastroenterology 1995; 39: 1351-1366.
  16. Жукова Е. Н. Дифференцированное участие активных медиаторов воспаления нейтрофилов в патогенезе хронического панкреатита. Сиб. журн. гастроэнтерол. и гепатол. 1997; 4-5: 176.
  17. Жукова Е. Н. Лизосомальные ферменты в механизмах обострения хронического панкреатита. Рос. гастроэнтеролог. журн. 1997; 1: 17-19.
  18. Norton L., Apte М., Haiber P. P 450 2EI is present in rat pancreas and is induced by chronic ethanol administration. Gastroenterology 1996; 110: 1280-1285.
  19. Жуков Н. А., Жукова Е. Н., Климова С. К. Механизм активации и роль перекисного окисления липидов при обострении хронического панкреатита. Тер. арх. 1989; 2: 15-18.
  20. Жукова Е. Н. Окислительный стресс при гиперактивации процессов перекисного окисления липидов у больных хроническим рецидивирующим панкреатитом. Там же. 2000: 3:68-71.
  21. Sunamura М., Shibuya К., Yamauchi J. et al. Microcirculatory derangement and ischemia of the pancreas. Nippon Geka Gakkai Zasshi 1999; 100(5): 342-346.
  22. Otamiri Т., Sjodahl R. Oxygen radicals: their role in selected gastrointestinal disorders. Dig. Dis. Sci. 1991; 9(3): 133-141.
  23. Denham W., Yang J., Fink G. et al. TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas. J. Surg. Res. 1998; 74(1): 3-7.
  24. Grimble R. F. Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz. 1994; 2(2): 175-185.
  25. Niederau C., Schultz H. U., Letko G. Involvement of free radicals in the pathophysiology of chronic pancreatitis: potential of treatment with antioxidant and scavenger substances. Klin. Wschr. 1991; 69(23): 1018-1024.
  26. Kuklinski В., Zimmermann Т., Schweder R. Decreasing mortality in acute pancreatitis with sodium selenite. Clinical results of 4 years antioxidant therapy. Med. Klin. 1995; 90: 36-41.
  27. Ijuin H. Evaluation of pancreatic exocrine function and zinz absorption in alcoholism. Kurumc Med. J. 1998; 45(1): 1-5.
  28. Alvarez C., Bass B. L. Role of transforming growth factor-beta in growth and injury response of the pancreatic duct epithelium in vitro. J. Gastrointest. Surg. 1999; 3(2): 178-184.
  29. Fogar P., Pasqaali C., Basso D. et al. Transforming growth factor beta, fibrogenesis and hyperglycemia in patients with chronic pancreatitis. S. J. Med. 1998; 29(5): 277-287.
  30. Menke A., Geerling I., Giehl K. et al. Transforming growth factor-beta-induced upregulation of transforming growth factorbeta receptors expression in pancreatic regeneration. Biochim. Biophys. Acta 1999; 1449(2): 178-185.
  31. Kazbay K., Tarnasky P. R., Hawes R. H. et al. Increased transforming growth factors beta in pure pancreatic juice in pancreatitis. Pancreas 2001; 22(2): 193-195.
  32. Mutter-Pillasch F., Menke A., Yamaguchi H. et al. TGF beta and the extracellular matrix in pancreatitis. Hepatogastroenterology 1999; 46(29): 2751-2756.
  33. Жукова Е. Н. Поли- и мононуклеарные фагоциты в механизмах хронического воспаления и развития фиброза в поджелудочной железе. Там же. 1999; 3: 28-31.
  34. Talamini G., Bassi С., Falconi M. et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig. Dis. Sci. 1999; 44: 1301-1311.
  35. Bynum T. E., Solomon T. E., Johnson L. R. et al. Inhibition of exocrine pancreatic secretion in man by cigarette smoking. Gut 1972; 13: 361-365.
  36. Mithofer K., Fernandez-Del Castillo C., Frick T. W. et al. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 1995; 109: 239- 246.
  37. Cope O., Culver P. J., Mixer Jr. С. G. et al. Pancreatitis, a diagnostic clue to hyperparathyroidism. Am. Surg. 1957; 145: 857-863.
  38. Bess M. A., Edis A. J., van Heerden J. A. Hyperparathyroidism and pancreatitis. Chance or a causal association? J. A. M. A. 1980; 243: 246-247.
  39. Merkord J., Jonas L., Weber H. et al. Acute interstitial pancreatitis in rats induced by dibutylin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas 1997; 112: 1664-1672.
  40. Merkord J., Weber H., Sparmann G. et al. The course of pancreatic fibrosis induces by dibutylin dichloride (DBTC). Ann. N. Y. Acad. Sci. 1999; 880: 231-237.
  41. Leivh M. M., Hoppe-Seyler P., Gerok W. Origin and development of exocrine pancreatic insufficiency in experimental renal failure. Gut 1994; 35: 401-407.
  42. Dinoso V. P. Jr., Mitrthy S. N.. Saris A. L. et al. Gastric and pancreatic function in patients with end-stage renal disease. J. Clin. Gastroenterol. 1982; 4: 321-324.
  43. Feldstein J. D., Johnson F. R., Kallick С. A. et al. Acute hemorragic pancreatitis and pseudocyst due to mumps. Ann. Surg. 1974; 180: 85-88.
  44. Imrie С. W., Ferguson J. C., Sommerville R. G. Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut 1977; 18: 53-56.
  45. Kibrick S., Benirschke K. Severe generalised disease occurring in newborn period and due to infection with coxsackie virus, group B. Pediatrics 1958; 22: 857-875.
  46. Capner P., Lendrum R., Walker G. Viral antibody studies in pancreatic disease. Ibid. 1975; 16: 886-870.
  47. Ozsvar Z., Deak J., Pap A. Possible role of coxsackie-B virus infection in pancreatitis. Int. J. Pancreatol. 1992; 11: 105- 108.
  48. Ectors N., Maillet В., Aerts R. et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 263-268.
  49. Gschwantler M., Kogelbauer G., Klose W. et al. The pancreas as a site of granulomatous inflammation in Crohn's disease. Gastroenterology 1995; 108: 1246-1249.
  50. Cavalimi G. Is chronic pancreatitis a primary disease of the pancreatic ducts? A new pathogenetic hypotesis. Ital. J. Gastroenterol. 1993; 25: 400-407.
  51. Kawaguchi K., Koize M., Tsuruta K. et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum. Pathol. 1991; 22: 387-391.
  52. Erkelens G. W., Vleggaar F. P., Lesterhuis W. et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-44.
  53. Frulloni L., Bovo P., Brunelli S. et al. Elevated serum levels of antibodies to carbonic anhydrase I and II in patients with chronic pancreatitis. Pancreas 2000; 20: 382-388.
  54. Kino-Ohsaki J., Nishimori I., Morita M. et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology. 1996; 110: 1579-1586.
  55. Layer P., Yamamoto H., Kalthoff L. et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481 - 1487.
  56. Pfutzer R. H., Barmada M. M., Brunskil A. P. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic of chronic pancreatitis. Gastroenterology 2000; 119: 615-623.
  57. Rossi L., Whitcomb D. C., Ehrlich G. D. et al. Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Ibid. 1998; 17: 278- 280.
  58. Witt H., Luck W., Hennies H. С. et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type I are associated with chronic pancreatitis. Nat. Genet. 2000; 25: 213- 216.
  59. Walsh T. N.. Rode J., Theis B. A. et al. Minimal change chronic pancreatitis. Gut 1992; 33: 1566-1571.
  60. Araki Т., Ueria M., Ogawa К et al. Histological pancreatitis in end-stage renal disease. Int. J. Pancreatol. 1992; 12: 263-269.
  61. Comfort M.. Steinberg A. Pedigree of a family with hereditary relapsing pancreatitis. Gastroenterology 1952; 21: 54-63.
  62. Whitcomb D. С. Genetic predispositions to acute and chronic pancreatitis. Med. Clin. N. Am. 2000; 84: 531-547.
  63. Жукова E. Н. Дефицит ингибитора протеаз а I-антитрипсина - фактор риска в развитии и обострении различных клинических форм хронического панкреатита. Рос. гастроэнтеролог, журн. 1998; 2: 10-12.
  64. Жукова Е. Н. Сывороточный интерлейкин-8 в различные периоды течения хронического рецидивирующего панкреатита и его участие в патогенезе заболевания. Там же. 2001; 3: 15-18.
  65. Heath D. I., Cruickshank A., Gudgeon М. et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-43.
  66. Aspinall R. J., Lemoine N. R. Gene therapy for pancreatic and biliary malignancies. Ann. Oncol. 1999; 10: 188-192.
  67. Di Sebastiano P., di Moda F. F., di Febbo С. et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000; 47(3): 423-428.
  68. Aleynik S. I., Leo M. A., Aleynik M. K. et at. Alcohol-induced pancreatic oxidative stress: protection by phospholipid repletion. Free Radic. Biol. Med. 1999; 26(5): 609-619.
  69. Ashizawa N., Niigaki M., Hamamoto N. et al. The morphological changes of exocrine pancreas in chronic pancreatitis. Histol. Histopathol. 1999; 14(2): 539-552.
  70. Friess H., Zhu Z. W., di Mola F. F. et al. Nerve growth factor and its light-affinity receptor in chronic pancreatitis. Ann. Surg. 1999; 230(5): 615-624.
  71. Zhu Z. W., Friess H., Wang L. et al. Brain-derived neurotrophic factor (BDNF) is upregulated and associated with pain in chronic pancreatitis. Dig. Dis. Sci. 2001; 46(8): 1633-1639.
  72. Glasbrenner В., Adler G. Evaluating pain and the quality of life in chronic pancreatitis. Int. J. Pancreatol. 1997; 22(3): 163- 170.
  73. Manes G., Pieramico O., Uomo G. Pain in chronic pancreatitis: recent pathogenetic findings. Minerva Gastroenterol. Dietol. 1992; 38(3): 137-143.
  74. Rutsky E. A., Rdoards M., Van Dyke J. A. et al. Acute pancreatitis in patients with end-stage renal disease without transplantation. Arch. Intern. Med. 1986; 146: 1741-1745.
  75. Shah R. J., Martin S. P. Endoscopic retrograde cholangiopancreatography in the diagnosis and management of pancreatic disease. Curr. Gastroenterol. Rev. 2000; 2: 133-145.
  76. Sherman S. Idiopathic acute recurrent pancreatitis: endoscopic approach to diagnosis and therapy. Gastrointest. Endosc. 1992; 38: 261.
  77. Sherman S., Jamidar P., Reber H. Idiopathic acute pancreatitis: endoscopic approach to diagnosis and treatment. Am. J. Gastroenterol. 1993; 88: 1541.
  78. Ахмедов В. А., Жуков Я. А. Повышение базального давления сфинктера Одди - причина развития панкреато-холедохо-пузырного и билиарно-панкреатического рефлюксов. Рос. гастроэнтеролог, журн. 2000. 4: 59-64.
  79. Sherman S., Troiano F. P., Hawes R. H. et al. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Ibid. 1991; 86: 586-589.
  80. Kuo W. H., Pasricha P., Kalloo A. The role of sphincter ot Oddi Surg manometry in the diagnosis and therapy of pancreatic disease. Gastrointest. Endosc. Clin. N. Am. 1998; 8: 79-85.
  81. Guelrud M., Plaz J., Mendoza S. et al. Endoscopic treatment in type II pancreatic sphincter dysfunction Gastrointest. Endoscopy 1995; 52: 398.
  82. Freeman M. L., Nelson D. В., Sherman S. et al. Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med. 1996: 335: 909-918.
  83. Tarnasky P., Pa/esch Y., Cunningham J. et al. Pancreatic stenting prevent pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-1524.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies